Catalyst Wire Dossier Catalyst Wire Dossier

AAT-023 (Zuragen) solution

AAT-023 · Ash Access Technology
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AAT-023 (Zuragen) solution, covering 2008-03-05 to 2008-03-05. Get the full timeline:

Most recent: Clinical Trial Update: A Multi-Centered, Two-Arm, Randomized Study Comparing the Effects of AAT-023 (Zuragen) Solution, and Heparin on the Incidence of Catheter Related Blood Stream Infections in Tunneled Chronic Central Venous Catheters for Dialysis [Phase 3]

See pricing